The disease burden associated with Campylobacter spp. in Germany, 2014.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
21
11
2018
accepted:
30
04
2019
entrez:
16
5
2019
pubmed:
16
5
2019
medline:
21
1
2020
Statut:
epublish
Résumé
Bacteria of the genus Campylobacter are an important cause of human illness worldwide. Campylobacter infections are expressed as gastroenteritis and can lead to severe sequelae like reactive arthritis, Guillain-Barré syndrome, irritable bowel syndrome and inflammatory bowel disease. In Germany, Campylobacter-associated gastroenteritis cases are notifiable but there is no reporting obligation for the sequelaes and the disease burden is clearly underestimated. The aim of our study was to quantify reliably the current disease burden of all Campylobacter spp.-associated diseases for Germany with the method of disability-adjusted life years (DALYs). DALYs combine mortality and morbidity in a single summary measure, whereby one DALY represents the loss of one year in full health. For acute gastroenteritis, we estimated 967 DALYs of which only 484 DALYs were detected within the reporting system. Overall, we estimated that 8811 DALYs were caused by the campylobacter-related diseases known so far. 98% of the DALYs were associated with morbidity and 2% with mortality. Mortality was caused by the health outcomes Gastroenteritis and Guillain-Barré syndrome exclusively.
Identifiants
pubmed: 31091282
doi: 10.1371/journal.pone.0216867
pii: PONE-D-18-31994
pmc: PMC6519833
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216867Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Epidemiol Infect. 2015 Oct;143(13):2795-804
pubmed: 25633631
BMC Public Health. 2014 Nov 22;14:1203
pubmed: 25416162
Epidemiol Infect. 2000 Dec;125(3):505-22
pubmed: 11218201
Semin Arthritis Rheum. 2007 Aug;37(1):48-55
pubmed: 17360026
Emerg Infect Dis. 2011 Sep;17(9):1581-90
pubmed: 21888782
Bull World Health Organ. 2015 Aug 1;93(8):540-549C
pubmed: 26478611
PLoS One. 2018 Jan 11;13(1):e0190409
pubmed: 29324759
Int J Infect Dis. 2014 Nov;28:176-85
pubmed: 25281904
J Clin Gastroenterol. 2009 Jul;43(6):534-40
pubmed: 19262407
Arch Dis Child. 1987 Jul;62(7):733-5
pubmed: 3632024
Int J Food Microbiol. 2015 Mar 2;196:84-93
pubmed: 25528537
Gut. 2002 Sep;51(3):410-3
pubmed: 12171965
Bull World Health Organ. 1994;72(3):429-45
pubmed: 8062401
J Health Econ. 1997 Dec;16(6):703-30
pubmed: 10176780
Risk Anal. 2010 May;30(5):743-52
pubmed: 19645753
Int J Food Microbiol. 2010 Sep 1;142(3):330-40
pubmed: 20674055
Popul Health Metr. 2008 Dec 29;6:7
pubmed: 19114007
Epidemiol Infect. 2013 Aug;141(8):1625-39
pubmed: 23013659
Epidemiol Infect. 2010 Nov;138(11):1650-6
pubmed: 20223049
EBioMedicine. 2017 Feb;15:100-111
pubmed: 27965105
Rheumatology (Oxford). 2002 Mar;41(3):312-8
pubmed: 11934969
Int J Food Microbiol. 2012 Jun 1;156(3):231-8
pubmed: 22541392
PLoS One. 2013 Nov 20;8(11):e79740
pubmed: 24278167
Arch Dis Child. 1991 Jun;66(6):706-8; discussion 708-9
pubmed: 2053793
Brain. 1996 Dec;119 ( Pt 6):2053-61
pubmed: 9010009
Epidemiol Infect. 2013 Oct;141(10):2051-7
pubmed: 23228443
Ann Neurol. 1994 Dec;36(6):859-63
pubmed: 7998771
Epidemiol Infect. 2014 Oct;142(10):2024-35
pubmed: 24480146
Popul Health Metr. 2015 Apr 03;13:10
pubmed: 26778920
Scand J Public Health. 2012 May;40(3):294-302
pubmed: 22312030